Biotechnology

Biomanufacturing (22)
Bioscience (62)
Biotechnology (220)
Biotechnology companies (70)
Biotechnology industry (7)
Biotechnology product (5)
Red biotechnology (40)
White biotechnology (6)

Synopsis: Domenii: Biotech: Biotech generale: Biotechnology:

advance manufacturing and biotechnology. e started with ICT because it the easiest thing to start.

"It's an interesting way that Bluetooth can interact with the biotech industry.##Other personal health sensors that use Bluetooth include the Cardiopad,

especially by using emerging biotechnologies, and might encourage diversity in the kinds of architectures we produce.

This promising compound will soon join the regulatory pipeline of a biotech company called Rxbio Inc,

#Biogen idec Columbia to Conduct Collaborative Genetics Research Biogen idec and Columbia University Medical center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease

The agreement will integrate genomics research conducted at Columbia with Biogen idec understanding of disease mechanisms and pathways,

Biogen idec. e are committed to working with leading institutions such as Columbia to advance basic genetic research and,

The collaboration will enable Biogen idec and Columbia to investigate the genomes of patients showing unusual treatment responses

a leading developmental biologist with Montana State university, told Bioscience Technology. Pera was uninvolved in the research.""The paper uncovers fundamentals in producing the earliest stage germ cells.

told Bioscience Technology. think this is a major leap forward.""Built on Kyoto University research The work is built on research done by the Kyoto University lab of stem cell researcher Mitinori Saitou.

Hanna told Bioscience Technology. or example, H3k27me3, a repressive chromatin mark, is depleted over developmental regulators in naive conditions.

Hanna concluded to Bioscience Technology. was not surprised in a way. I was confident that the failure with conventional ipscs would be resolved by toggling them back towards an alternative more naive state.

biotechnology and information technologies to develop an artificial hand that patients were able to experience, to some degree,

#An innovative production platform for micro-products Micro-products have become increasingly important in the medical, biotechnology, consumer and automotive sectors.

We believe that the PEF will become the new world standard for polyester bottles. with the possibilities it opens up for future work in vaccine discovery was recognised with the naming of Professor Lomonossoff as Innovator of the Year 2012 by the Biotechnology and Biological sciences Research Council

was recognised with the naming of Professor Lomonossoff as Innovator of the Year 2012 by the Biotechnology and Biological sciences Research Council (BBSRC), U s

Bringing together biologists, chemists, microbiologists, biochemists, molecular geneticists and biotechnologists from universities, biotech firms and food and pharmaceutical multinationals from around Europe, Polymode has identified now its first eadingand ritingenzymes.

but also for public health budgets and for the European biotechnology industry n

#0. 05mm: a new accuracy standard for industrial robots An EU-funded project brought together industry

#PHARMA-PLANTA#Harnessing plant biotechnology to revolutionise pharmaceutical production The hope is that the drug will prove effective in preventing HIV infection.

"Discovered by one of the four private commercial partners in the project, Austrian biotech company Polymun,

the success of PHARMA-PLANTA"is a springboard for European plant biotechnology and will enable many important medical products to be realised".

The National institutes of health and the Mathematical Biosciences Institute of the National Science Foundation supported the work.

The National institutes of health the Rice Century Scholars Program and a Hamill Innovation Award by the Rice university Institute of Biosciences and Bioengineering supported the research.

Giaccia and Cochran are scientific advisors to Ruga Corp. a biotech startup in Palo alto that has licensed this technology from Stanford.

The group includes researchers at the Icahn School of medicine at Mount sinai Washington University the University of Texas Southwestern Medical center Howard University and Microbiotix Inc. a Massachussetts biopharmaceutical company Source:

and Molecular Biosciences. e have discovered genes that make up the cell wall of the strep bacteria, which is composed mainly of the group A carbohydrate or GAC,

and may be suited better for a biotech company, he says. e focus more on the performance of the hydrogels and the underlying molecular mechanisms The National institutes of health,

says Robert Krug, professor of molecular biosciences at University of Texas at Austin. In addition to countering the body defense mechanisms,

and the Institute for Collaborative Biotechnologies supported the work. Source: Caltechyou are free to share this article under the Creative Commons Attribution-Noderivs 3. 0 Unported license t

The Division of Chemical sciences Geosciences and Biosciences of the Office of Basic energy Sciences of the US Department of energy supported the work.

and the Army Research Office through the Institute for Collaborative Biotechnologies at Caltech supported the research.

or female says Peter Koopman a professor from the University of Queensland s Institute for Molecular Bioscience. ost mammals including humans

Their results are published in the journal Nature Biotechnology. One billion acres#When Bt crops were introduced first the main question was how quickly would pests adapt

and will be run by Arthur Levinson, chairman and ex-CEO of biotech company Genentech. Google gave exclusive access to Time magazine for a story on the new venture.

With some longer term, moonshot thinking around healthcare and biotechnology, I believe we can improve millions of lives.

That s exactly what#Sanaria, a biotechnology founded in 2003 by long-time malaria researcher Stephen Hoffman and based in a suburb of Washington,

Includes the broad redefinition and expansion of biotechnology, with the ultimate goals of being able to design,

like a living cockroach, says Ángel Goñi Moreno of the National Center for Biotechnology in Madrid,

allows Medifocus to partner up with other biotech companies in helping to develop and commercialize targeted thermoactivated/released drugs and gene products which,

An expert on sustainable agriculture and the potential environmental risks of biotechnology Mellon holds a doctorate in molecular biology and a law degree.

Only this year did agricultural biotech company Monsanto introduce its first drought tolerant seed variety Droughtgard. According to the Monsanto website the variety has produced a five-bushel

and biofuels and the ability to create custom-made yeast would provide useful too for the biotech industry.

the Wellcome Trust has joined forces with the Indian government's Department of Biotechnology to fund postdoctoral researchers in the country through a new,

For example, Riley has been collaborating with Sangamo Biosciences, a biotechnology company based in Richmond, California, to determine whether the company's technique for snipping out targeted genes could be used to delete the CCR5 gene.

Sangamo announced last week that it has launched a Phase I clinical trial that will involve removing a sample of the participant's T cells,

They will be awarded every two years starting in 2014, to global leaders in the fields of sustainable development, biopharmaceutical science, Chinese studies and the rule of law.

October 2010 Biotechnology company Geron doses first patient in world s first clinical trial to test an ES-cell product.

Former heads of the biotech company Geron, based in Menlo Park, California, last week announced an agreement to acquire stem-cell assets including the company s flagship human ES-cell trial, in

It was in August 2009, that Sherley and Theresa Deisher, the chief executive of AVM Biotechnology in Seattle,

Lu says that the approach could also be useful in biotechnology. Using simple forms of these addressable switches,

as well as the launch of several SMALL CAR-focused biotechnology firms. And Sadelein says that he is an investigator on a trial with the Dana-Farber Cancer Institute in Boston

"It s a huge unmet need, says David Ferreiro, a biotechnology analyst with investment bank Oppenheimer & Company in New york,

Personalis, down the road in Menlo Park, offers sequencing services and interpretation for clinicians and pharmaceutical and biotechnology companies.

The study, conducted by an international ALS consortium that includes scientists and clinicians from Columbia University Medical center (CUMC), Biogen idec,

and Hudsonalpha Institute for Biotechnology, was published today in the online edition of Science. he identification of TBK1 is exciting for understanding ALS pathogenesis,

and Tim Harris, Phd, DSC, Senior vice president, Technology and Translational Sciences, Biogen idec. hese findings demonstrate the power of exome sequencing in the search for rare variants that predispose individuals to disease and in identifying potential

but this is a perfect example of a large, complex project that required many parts, with equal contributions from Biogen idec.

including bladder cancer. rology hasn gotten really the benefit of improvement in the biotech revolution. This type of technology can revolutionize how we do drug therapy in urology,

Indeed, collecting clinical data is a major challenge in spinning biotechnology out of the lab, notes Cima,

Biologics is the fastest growing field in biotech because it gives you the ability to do highly predictive designs with unique targeting capabilities says senior author Mehmet Fatih Yanik an associate professor of electrical engineering and computer science and biological engineering.

and electrical engineering and computer science the researchers described their findings in the Sept. 21 issue of Nature Biotechnology.

In the new Nature Biotechnology study graduate students Robert Citorik and Mark Mimee worked with Lu to target specific genes that allow bacteria to survive antibiotic treatment.

which have numerous applications in a variety of fields including biotechnology. He adds This work cleverly combines low-hysteresis droplet movement with low-magnetic-field-driven droplet propulsion to achieve impressive capabilities.

The company which aims to leverage biotechnology as a way to solve environmental issues is also modifying their system to generate value from wastewater in agricultural and military fields,

We are leveraging biotechnology to provide the highest return on investment for managing water. To that end, Cambrian is working on other projects that leverage exoelectrogenic microbes to treat wastewater.

Meeting at MIT in 2006 over a shared fondness for biotech, Silver, then a research scientist in MIT Space Systems Lab,

is to leverage biotechnology to advance a sustainable ndustrial ecology, where the waste of industry is recycled to create energy

The findings described in the March 30 issue of Nature Biotechnology offer the first evidence that this gene-editing technique known as CRISPR can reverse disease symptoms in living animals.

and one of the lead authors of the Nature Biotechnology paper. This work shows that CRISPR can be used successfully in adults

and the Institute for Collaborative Biotechnologies through the U s army Research Office u

#Resistance is futile Cisplatin is given a chemotherapy drug to more than half of all cancer patients. The drug kills cells very effectively by damaging nuclear DNA but if tumors become resistant to cisplatin they often grow back.

In the previous version of the system reported last December in Nature Biotechnology the researchers used mass spectrometry to distinguish the fragments by their mass.

Now, Semprus Biosciences, a startup co-founded by two MIT alumni Christopher Loose Phd 7

the biomaterial has positioned Semprus as a fast-growing biotech firm in Kendall Square. In its six years, the startup seed-funded, in part,

The new technology is described in a paper appearing in the journal Nature Biotechnology, written by MIT Polina Anikeeva and 10 others.

Earlier this month, MIT spinout Microchips Biotech partnered with a pharmaceutical giant to commercialize its wirelessly controlled, implantable,

Invented by Microchips Biotech cofounders Michael Cima, the David H. Koch Professor of Engineering, and Robert Langer, the David H. Koch Institute Professor, the microchips consist of hundreds of pinhead-sized reservoirs,

and osteoporosis. Now Microchips Biotech will begin co-developing microchips with Teva Pharmaceutical, the world largest producer of generic drugs,

Microchips Biotech says these microchips could also improve medication-prescription adherence a surprisingly costly issue in the United states. A 2012 report published in the Annals of Internal medicine estimated that Americans who don stick to prescriptions rack up $100 billion to $289 billion

Microchips Biotech will continue work on its flagship product, a birth-control microchip, backed by the Bill and Melinda Gates Foundation,

Cima, who now serves on the Microchips Biotech board of directors with Langer, sees this hormone-releasing microchip as one of the first implantable rtificial organsecause it acts as a gland. lot of the therapies are trying to chemically trick the endocrine systems Cima says. e are doing that with this artificial organ we created. ild ideasinspiration for the microchips came in the late 1990s,

For years, the technology underwent rigorous research and development at Microchips Biotech. But in 2011, Langer and Cima,

EMS innovationsmicrochips Biotech made several innovations in the microelectromechanical systems (MEMS) manufacturing process to ensure the microchips could be commercialized.

To do so, Microchips Biotech modified a cold-welding ongue and grooveprocess. This meant depositing a soft,

The research team received funding for their study from the Israel Ministry of Science and Technology the European Research Council and the Biotechnology and Biological sciences Research Council.

In their latest paper, researchers from Cardiff University's Schools of Biosciences and Physics showed that non-fluorescing nanodiamonds (diamonds without defects) can be imaged optically

Professor Paola Borri from the School of Biosciences, who led the study, said:""This new imaging modality opens the exciting prospect of following complex cellular trafficking pathways quantitatively with important applications in drug delivery.

Dr. Tal Dvir and his graduate student Michal Shevach of TAU's Department of Biotechnology, Department of Materials science and engineering,

"said Ali Yetisen, a Phd candidate in the Department of Chemical engineering & Biotechnology, who led the research.

That s just what a group of MIT researchers have done in a new study published in the journal Nature Biotechnology.

Genetic engineering and Biotechnology News explains: The team began studying reflectin to discern how it enables the squid to change color

Church also is cofounder of the biotech firm Editas Medicine. He said he expects the company will enter clinical trials next year on a gene-editing process for humans e

and involved a collaboration between three universities and a biotech company. Both groups designed artificial versions of antibodies, the Y-shaped molecules made by the immune system to target pathogens.

Professor Shin'ichi Ishiwata (Graduate school of Advanced Science and Engineering) and Research Assistant Makito Miyazaki's (Research Institute for Science and Engineering) research team at the Waseda Bioscience Research Institute

"said Liang Xu, associate professor of molecular biosciences and corresponding author of the paper. The results hold promise for treating a broad array of cancers in people.

The study, funded by the Engineering and Physical sciences Research Council and the Biotechnology and Biological sciences Research Council, is published in Proceedings of the National Academy of Sciences.

MIT is negotiating an exclusive license agreement with Lyndra, an early-stage biotechnology company developing novel oral drug-delivery systems,

a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense

Most tech innovation in agriculture was concentrated narrowly in biotechnology and seed genetics, and both investment and innovation was limited to players with close ties to the ag sector.

and the sector is described often as being more horizontal than vertical (we tracked 16 subcategoriess diverse as biotech,

and plant trait company Arcadia Biosciences recently filed a $86 million IPO. And in what might seem like a jump-the-shark moment while still in the first inning

and the biopharmaceutical company Metabolic Solutions Development Co. The company is involved in clinical trials that are evaluating the drug compound MSDC-0602 as a treatment for diabetes.

"said Ghodbane, who now works in biopharmaceutical research and development at Glaxosmithkline. The breakthrough also requires one-tenth of the chemicals used in a conventional multiplex immunoassay,

#Oxman Revolutionizes Biomanufacturing with Living, 3d printed Wearable If a Makerbot Replicator 3d printer can be used in pharmacological research labs for advances studies on how to administer cancer fighting drugs,

and physical bioscientist Peter Zwart have introduced new mathematical theory and an algorithm, which they call ulti-tiered iterative phasing (M-TIP),

who is a member of the Physical Biosciences Division at Berkeley Lab. lthough fluctuation scattering was proposed first 38 years ago,

who earned his doctorate in biomedical engineering at Rutgers and now works in biopharmaceutical research and development at Glaxosmithkline.

The North carolina Biotechnology Center awarded a $50, 000 Technology Enhancement Grant to the School to help develop the technology into a viable treatment that can be licensed and commercialized."

#Self-Assembled DNA NANOSTRUCTURES Could Be used as Smart Drug-Delivery Vehicles Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal.

and the group has published just recently two research articles regarding DNA-based applications in biotechnology and molecular medicine.

Many of the methods routinely used in the biosciences are based on the specific modification of proteins, in particular antibodies,

One of Tkaczyk co-authors on the research was Rebecca Richards-Kortum, Rice Malcolm Gillis University Professor, director of the Institute of Biosciences and Bioengineering and of Rice 360°:

But so far, scientists have had only access to a limited variety of biosensors that have little relevance to the biomanufacturing of valuable chemicals.

which we would rely on biomanufacturing for the clean production of chemical and pharmaceutical commodities, "said Wyss Institute Founding Director Donald E. Ingber, M d.,Ph d,

a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense

as a biotechnology company with expertise in developing antibodies, they are in a position to act on it

and to be replaced with manufacturing at the point of care specific threat response without requiring specific preparedness. ao told Tuesday conference moving biomanufacturing to the front lines echoes the decentralisation of pharma supply chains to civilians,

Rao told Tuesday conference moving biomanufacturing to the front lines echoes the decentralisation of pharma supply chains to civilians,

and professor in the department of Anesthesiology and Radiology at Stony Brook University School of medicine in New york told Bioscience Technology that it is too early to comment on humans,

Benveniste told Bioscience Technology. Read More: Researchers Discover Missing Link Between Brain and Immune Systemshe explained how the system lushesout waste:

Benveniste told Bioscience Technology. Benveniste and colleagues used dynamic contrast magnetic resonance imaging (MRI) to image the glymphatic pathway at work in rodentsbrains.

Bioscience Technology. Imaging testing in humans is needed still. Up next Benveniste and colleagues are working to study how the glymphatic system can be controlled

Now MIT spinout AIM Biotech has developed a microfluidics device based on years of research that lets researchers co-culture multiple cell types in a 3d hydrogel environment that mimics natural tissue.

said AIM Biotech cofounder Roger Kamm, the Cecil H. Green Distinguished Professor in MIT departments of mechanical engineering and biological engineering. f you want realistic models of these processes,

AIM Biotech will begin deploying the commercial devices to 47 research groups in 13 countries for user feedback.

AIM Biotech devices, on the other hand, he said, can be put directly under the microscope like a traditional plate,

IM Biotech launched in Singapore in 2012, under current CEO Kuan Chee Mun, who Kamm met through SMART.

AIM Biotech microfluidics device produces a similar microenvironment: When endothelial cells are seeded into the side channels or the central gel region,

AIM Biotech may offer to more accurately screen cancer drugs for pharmaceutical companies. In fact, he said, AIM Biotech recently discovered that its devices revealed discrepancies in some clinically tested therapeutics.

In a study published in Integrative biology, MIT researchers used Kamm's microfluidics technology to screen several drugs that aim to prevent tumors from breaking up

professor at the Department of Biosciences and Nutrition at Karolinska Institutet and also affiliated to the Scilifelab facility.

capable of on-demand biomanufacturing new classes of proteins. his manufacturing technology will enable scientists to decrypt the phosphorylation odethat exists in the human proteome,

. who now works in biopharmaceutical research and development at Glaxosmithkline, published their results in the journal Lab on a Chip in addition to being able to use less fluid,

biotechnology and medical treatments. The study appears September 21 in Nature Materials. he very simple design rules that we have discovered provide a powerful engineering tool for many biomedical

and biotechnology applications, said Ashutosh Chilkoti, chair of the Department of Biomedical engineering at Duke. e can now,

a professor of biotechnology and bioengineering at The swiss Federal Institute of technology in Zurich, described this experiment as an legant proof of conceptthat could lead to greatly improved treatments for viral infection. entinel designer cells engineered with the DNA sense

physiology and biotechnology and associate professor of engineering at Brown. e knew it was a relatively high-throughput system,

the Wellcome Trust and the Biotechnology and Biological sciences Research Council will be published in the science journal Oncogene on 5 october 2015.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions.

The historical irony is that Europe once led in biotech: In 1983, Marc Van Montagu and Jeff Schell at the University of Ghent in Belgium introduced the world to modern plant genetic engineering.

because biotech traits make them cheaper. Yet these same traits such as herbicide tolerance and insect resistance are barred now widely from domestic use.

where anti-Western conspiracy theories about biotech companies have become part of the ruling party ideology. According to Tobaiwa Mudede, a crony of President Robert Mugabe, exual dysfunction is a huge problem in the U s a,

I was interrupted by an organic farmer who said he was determined never to grow biotech crops. His grounds?

Yet from drought tolerant maize to virus-resistant cassava, many biotech traits are being developed that could quickly improve the livelihoods of poorer African farmers.

so that faculty and students across our campuses will successfully compete for grant dollars and launch bioscience ventures."

"In close collaboration with his TUM colleagues Johannes Buchner, professor of biotechnology and Sevil Weinkauf, professor of electron microscopy, Reif determined that the small heat shock protein uses a specific nonpolar beta-sheet structure pile in its center

The Córdoba-based company Canvax Biotech has participated also in the development of the patent. A nontoxic drug One of the major advantages of the drug is that it is nontoxic.

In the last two months, the research project has received funding of over#124,930 from the public sector from the Ministry of Economy and Finance and the firm Canvax Biotech SL and#20

"said Ellington, professor in the Department of Molecular Biosciences and member of the UT Center for Systems and Synthetic biology."

"What we found may have a big impact on future plant biotechnology research, "Dr Bally said."

and biotechnology can join forces.""Professor Sels, is of KU Leuven Faculty of Bioscience Engineering (Centre for Surface Chemistry and Catalysis),

and Dr Dusselier, KU Leuven Faculty of Bioscience Engineering (Centre for Surface Chemistry and Catalysis) and California Institute of technology i

#New half-fat soft cheese solution Arla Foods Ingredients has developed a whey protein solution that enables dairies to produce low-fat soft ripened cheeses that taste as good as the full-fat versions.

the researchers used biotechnology to create the proteins in bacteria. The polymer can then either be molded using heat

and are already in use as a platform for other applications by biotechnology companies. The University of Chicago team is currently investigating other enzymes that might benefit from monobody technology,

was funded by Cancer Research UK, the Wellcome Trust and the Biotechnology and Biological sciences Research Council h

Startup biotechnology company Kallistem in Lyon, France, revealed the breakthrough earlier this year, but now have taken out a patent describing the technique, in tandem with The french National Centre for Scientific research (CNRS).

In Seattle, researchers at the Fred Hutchinson Cancer Research center and the company Presage Biosciences designed a device called CIVO that includes up to eight needles arranged in an array.

"The Seattle researchers'work was funded by the National institutes of health and Presage Biosciences, and the MIT researchers'work was funded by the National Cancer Institute and Massachusetts-based biotech company Kibur Medical.

Follow Live Science@livescience, Facebook & Google+.+Original article on Live Science e

#Nepal Earthquake: Health Threats Loom Over Survivors The aftermath of the Nepal earthquake brings a risk of disease outbreaks including measles and diarrheal diseases among the survivors,

The research jointly lead by Professor Christoph Hagemeyer, Head of the Vascular Biotechnology Laboratory at Baker IDI Heart and Diabetes Institute and Professor Frank Caruso,

Owing to the above-mentioned merits, SPR biosensing is an outstanding platform to boost technological progress in the areas of medicine and biotechnology.

and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.

As they report Sept. 28 in Nature Biotechnology, this tool should provide fast and reliable characterization of the different mechanisms cellular proteins use to bind to DNA strands--information that could shed new light on the atomic-scale interactions within our cells

In this latest study, published in the journal Biotechnology for Biofuels("A microbial platform for renewable propane synthesis based on a fermentative butanol pathway"),scientists at the Universitys Manchester Institute of Biotechnology (MIB

more sustainable forms of energy as well as using biotechnology techniques to produce synthetic chemicals are currently being developed at The University of Manchester.

#Millions of liters of juice from 1 grapefruit (Nanowerk News) The Austrian Centre of Industrial biotechnology (acib) uses the positive aspects of synthetic biology for the ecofriendly production of a natural compound("Production of the sesquiterpenoid

"The challenge of the biotechnologists Tamara Wriessnegger and Harald Pichler in Graz was to produce Nootkatone in large quantities.

as a biopharmaceutical component or as a natural insect repellent.""We have installed new genetic information in the yeast Pichia pastoris,

The common biotech variant via Valencene and a chemical synthesis step is less ecofriendly, more difficult and expensive.

< Back - Next >

Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011